Calquence

An estimated 27,000 cases of the disease were diagnosed in the UK, France, Germany, Spain and Italy in 2024

The drug is now the only BTK inhibitor to be approved in the EU for first-line MCL

Up to 262 million people worldwide are affected by the chronic respiratory disease

It is hoped that the fixed-duration treatments will reduce the risk of adverse events and drug resistance

More than 27,500 people worldwide are affected by the rare form of non-Hodgkin lymphoma

Approximately 4,000 new cases of the disease are diagnosed in the UK every year

The rare form of non-Hodgkin lymphoma is estimated to affect more than 27,500 people globally

The rare form of non-Hodgkin lymphoma is estimated to affect more than 27,500 people globally

The indications are for adults with liver and lung cancers, and chronic lymphocytic leukaemia

The acquisition includes TeneoTwo’s phase 1 clinical-stage T-cell engager

AZD7442 is based on antibodies isolated from two patients who had recovered from COVID-19

Study will evaluate efficacy of drug in patients hospitalised with COVID-19